Universal Health Services (UHS) Price Target Cut to $203 by Baird

Baird analyst Michael Ha lowered Universal Health Services' (UHS) price target to $203, a 16.46% decrease, while maintaining a "Neutral" rating. UHS owns and operates acute care hospitals, behavioral health centers, and surgery centers. The average target price for UHS is $221.13, with a high estimate of $280.00 and a low estimate of $165.00, indicating an upside of 24.43% from the current price.

Title: Baird Adjusts Price Target for Universal Health Services

Baird analyst Michael Ha has recently adjusted the price target for Universal Health Services (UHS) to $203, a 16.46% decrease from the previous target of $243.00. Despite this downward revision, the rating remains "Neutral" [1]. UHS, a provider of acute care hospitals, behavioral health centers, and surgery centers, has seen varying analyst opinions on its stock performance.

The latest adjustment follows a series of recent changes in analyst ratings and price targets. On August 4, 2025, JP Morgan lowered its price target to $195.00, a 9.30% decrease [1]. Barclays raised its price target to $259.00 on July 30, 2025, marking a 0.78% increase [1]. B of A Securities downgraded the rating to 'Underperform' and lowered the price target to $185.00 on July 16, 2025, indicating a 13.95% decrease [1].

Universal Health Services Inc reported strong second-quarter 2025 results, with revenue increasing by 9.6% to $4.28 billion and net income rising by 22% to $353.2 million. The company's earnings per share (EPS) also improved, reaching $5.49 compared to $4.32 in the same period last year [2]. The company's stock price has seen a consensus recommendation of "Hold" from 22 brokerage firms, indicating a moderate view on the stock's potential [1].

Based on the one-year price targets from 17 analysts, the average target price for UHS is $221.13, with a high estimate of $280.00 and a low estimate of $165.00. This implies an average upside of 24.43% from the current price of $177.71 [1]. GuruFocus estimates the GF Value for UHS in one year to be $212.79, suggesting an upside of 19.74% [1].

Despite the recent downward revision in the price target, UHS continues to operate in a growing healthcare sector. The company's strong second-quarter results and positive analyst ratings indicate that the market remains optimistic about its future performance. However, investors should remain vigilant and conduct thorough due diligence before making investment decisions.

References:
[1] https://www.gurufocus.com/news/3062377/baird-adjusts-price-target-for-universal-health-services-uhs-to-203-uhs-stock-news
[2] https://finance.yahoo.com/news/universal-health-services-second-quarter-102031218.html